139 related articles for article (PubMed ID: 35142286)
1. Ganglion cell maturation in peripheral neuroblastic tumours of children.
Sarnat HB; Yu W
Clin Neuropathol; 2022; 41(3):101-113. PubMed ID: 35142286
[TBL] [Abstract][Full Text] [Related]
2. Maturation of metastases in peripheral neuroblastic tumors (neuroblastoma) of children.
Sarnat HB; Chan ES; Ng D; Yu W
J Neuropathol Exp Neurol; 2023 Sep; 82(10):853-864. PubMed ID: 37682248
[TBL] [Abstract][Full Text] [Related]
3. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
Molenaar WM; Baker DL; Pleasure D; Lee VM; Trojanowski JQ
Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
[TBL] [Abstract][Full Text] [Related]
4. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
Hicks MJ; Mackay B
Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
[TBL] [Abstract][Full Text] [Related]
7. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
8. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Hachitanda Y; Tsuneyoshi M; Enjoji M
Arch Pathol Lab Med; 1989 Apr; 113(4):381-4. PubMed ID: 2495784
[TBL] [Abstract][Full Text] [Related]
9. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
[TBL] [Abstract][Full Text] [Related]
10. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
12. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
13. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
Wen Y; Peng Y; Duan XM; Zhang N
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
[TBL] [Abstract][Full Text] [Related]
15. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
Munchar MJ; Sharifah NA; Jamal R; Looi LM
Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
[TBL] [Abstract][Full Text] [Related]
16. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
17. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors.
Ikuno N; Shimokawa I; Nakamura T; Ishizaka Y; Ikeda T
Pathol Res Pract; 1995 Mar; 191(2):92-9. PubMed ID: 7567689
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
Choi JH; Ro JY
Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
[TBL] [Abstract][Full Text] [Related]
19. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract][Full Text] [Related]
20. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
